Vice Chair, Global Health
Professor, Allergy and Infectious Dis.
Professor, Global Health
EducationMD Medicine, University of Washington, 2003
PhD Epidemiology, University of Washington, 2001
BA Chemistry, Religious Studies, Washington University, 1995
Ninth and Jefferson Building 12th Floor
908 Jefferson Street
Seattle, WA 98104
Dr. Baeten's research focuses on the prevention of HIV-1 and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV-1 transmission, and behavioral, translational, and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials that demonstrated the efficacy of oral tenofovir-based pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring for protection against HIV-1 acquisition. Current projects include a) a multinational open-label trial of the dapivirine vaginal ring for HIV-1 prevention in women (MTN-025/HOPE, through the NIH Microbicides Trials Network), b) implementation science work to deliver antiretroviral treatment and PrEP for HIV-1 prevention, c) studies exploring use of hormonal contraception as a risk factor for HIV-1 (including co-chairing the ECHO Study), and d) collaborative studies of immunologic and virologic factors that influence HIV-1 transmission.
HIV/AIDS and other STDs; women; Africa
In The News
Washington Researchers: Vaginal Ring May Be Highly Effective Against HIV
UW School of Public Health News, 07/22/2016
Vaginal ring may be highly effective against HIV
Vaginal ring may cut HIV infection risk if used correctly